The influence of acute and chronic coronary syndrome on the gut microbiome and downstream microbiome-derived metabolites—Microbiome in acute myocardial infarction—MIAMI-Trial
Basic Research in Cardiology · 13.08.2025 · 120 (5) · 913-924
DOI: 10.1007/s00395-025-01134-9 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift Basic Research in Cardiology, online erschienen am 13.08.2025. Verfasst von Daniel Messiha und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology and Vascular Medicine, West German Heart and Vascular Centre, University of Duisburg-Essen, Essen, Germany. Hauptthemen laut MEDLINE: Acute Coronary Syndrome, Bacteria, Gastrointestinal Microbiome, Myocardial Infarction. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Deutsche Forschungsgemeinschaft, Universitätsklinikum Essen.
Abstract (Originalsprache)
Cardiovascular diseases (CVD) are the leading cause of morbidity and mortality in the industrialized world. The gut microbiome influences CVD, through atherogenic metabolites like trimethylamine N-oxide (TMAO) or protective effects through short-chain fatty acids (SCFA) production. The specific alterations in the gut microbiome and downstream metabolites in acute coronary syndrome (ACS) and chronic coronary syndrome (CCS) remain unclear. We enrolled ACS patients within 24 h of clinical presentation with a follow-up of 28 days, using CCS patients as controls. Gut microbiome composition, downstream metabolites, and cardiovascular function were assessed at both baseline and follow-up. Microbiome-derived metabolites were analyzed and gut microbiome samples were characterized by 16S rRNA gene analysis. We enrolled 40 patients, with 20 patients each in the ACS and CCS group. Alpha diversity of the microbiome did not differ throughout the follow-up. After ACS gut microbiome composition changed during the follow-up period with increased levels of Butyricicoccus and Butyricoccaceae, a pattern not observed in the CCS cohort. Downstream analysis of microbiome-derived metabolites SCFA revealed increased serum levels of butanoic acid, while TMAO levels remained unchanged. This small prospective observational non-randomized study, suggests that ACS may trigger an enrichment of butanoic acid-producing bacteria in the gut microbiome, accompanied by an increase in serum butanoic acid levels over 28 days. No significant changes in TMAO were observed. These insights could help develop approaches to reduce the burden of CVD. As a small pilot study, these findings require validation in larger ACS cohorts. Trial registration NCT, NCT05456802, Registered 30 June 2022, https://clinicaltrials.gov/study/NCT05122689
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Cardiology and Vascular Medicine, West German Heart and Vascular Centre, University of Duisburg-Essen, Essen, Germany.
- Institute of Medical Microbiology, University of Duisburg-Essen, Essen, Germany.
- Department of Cardiology and Vascular Medicine, West German Heart and Vascular Centre, University of Duisburg-Essen, Essen, Germany. christos.rammos@uk-essen.de.
ORCID-Profile: Daniel Messiha, Christos Rammos
Förderung
- Deutsche Forschungsgemeinschaft
- Universitätsklinikum Essen
Zitieren
APA
Messiha, D., Lange, E., Tratnik, A., M Westendorf, A., Rinke, M., Lenz, S., Hendgen-Cotta, U. B., Buer, J., Rassaf, T., & Rammos, C. (2025). The influence of acute and chronic coronary syndrome on the gut microbiome and downstream microbiome-derived metabolites—Microbiome in acute myocardial infarction—MIAMI-Trial. Basic Research in Cardiology, 120(5), 913-924. https://doi.org/10.1007/s00395-025-01134-9
Vancouver
Messiha D, Lange E, Tratnik A, M Westendorf A, Rinke M, Lenz S, et al. The influence of acute and chronic coronary syndrome on the gut microbiome and downstream microbiome-derived metabolites—Microbiome in acute myocardial infarction—MIAMI-Trial. Basic Research in Cardiology. 2025;120(5):913-924. doi:10.1007/s00395-025-01134-9
BibTeX
@article{Messiha2025,
author = {Messiha, Daniel and Lange, Erik and Tratnik, Annika and M Westendorf, Astrid and Rinke, Miriam and Lenz, Stine and Hendgen-Cotta, Ulrike B and Buer, Jan and Rassaf, Tienush and Rammos, Christos},
title = {The influence of acute and chronic coronary syndrome on the gut microbiome and downstream microbiome-derived metabolites—Microbiome in acute myocardial infarction—MIAMI-Trial},
journal = {Basic Research in Cardiology},
year = {2025},
volume = {120},
number = {5},
pages = {913--924},
doi = {10.1007/s00395-025-01134-9}
}
EUVIMED